Download in PDF format

Boston, USA / Budapest, Hungary – May 22, 2012 – Mediso USA, distributor of the preclinical imaging portfolio of Mediso Medical Imaging Systems, a Hungarian developer and manufacturer of multi-modality in vivo imaging systems and the Massachusetts Life Sciences Center (MLSC) today announced the establishment of the company, based in Boston, Massachusetts. The new office, located in Boston’s Financial District, will provide an excellent opportunity for Mediso to serve and support the professional and academic user base in North America, including Canada, and especially the life sciences industry in the Massachusetts area. Mediso USA currently expects to grow to five employees over the next year.

Mediso USA, LLC, engages in the marketing, sale, application and technical support of in vivo imaging systems for life sciences research, including clinical and molecular diagnostics research development areas. Its technology platforms include positron emission technologies, nuclear medicine technologies and magnetic resonance technologies.

"Establishing the U.S. base of operations in Massachusetts was a straightforward decision for us," said Illes J. Muller, Managing Partner for Mediso USA. "Mediso already has strategic partnerships in the Greater Boston area, and there are several installations of imagers manufactured by Mediso found in New England. The presence of the pharma industry and elite academic, medical institutions make this state unique, enabling us an unparalleled opportunity to engage a variety of potential collaborators with ease."

"The U.S. and Canada have a large market potential for our services, and we now have a clear strategy for how to approach and serve the customers to increase our presence," said Istvan Bagamery, Founder and CEO of Mediso Medical Imaging Systems. "The direct presence and the high level of support are essential in this market, and we have an answer for our customers as to how they will receive it. We are very happy to have Illes on board in Boston, as he possesses in-depth knowledge about the imaging technology and application fields. Having a presence in Massachusetts will allow us to assist our customers from the early evaluation phase all the way through tendering and post-sales support as well."

Mediso has received several awards from international and Hungarian agencies, and has just recently received Frost & Sullivan’s "2012 European Preclinical Imaging New Product Innovation Award." The company also has active R&D efforts in preclinical and clinical imaging technology, employing more than 80 percent of its 150-plus employees in development.

"Investing in education, innovation and infrastructure is a winning growth strategy for Massachusetts and is the reason we lead the world in life sciences," said Governor Deval Patrick. "We welcome Mediso USA to the Massachusetts biotech supercluster and thank them for their commitment to growing here."

Through the Massachusetts Life Sciences Center, Massachusetts is investing $1 billion over 10 years in the growth of the state’s life sciences supercluster. These investments are being made under the Massachusetts Life Sciences Initiative, proposed by Governor Patrick in 2007, and passed by the State Legislature and signed into law by Governor Patrick in 2008.

Massachusetts officials met with Mediso at the 2013 BIO International Convention last month in Chicago. Mediso is the second company to announce the opening of offices in Massachusetts following this year’s show.

"We are excited to welcome Mediso USA to Massachusetts' life sciences ecosystem," said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center. "Mediso USA is part of a growing community of international life sciences companies that have chosen Massachusetts as the best place to expand and do business.  We are sure that they will find potential collaborators in both industry and academia working in the medical imaging space."

"Mediso’s decision to grow in Massachusetts highlights the strength of the cluster here in the Commonwealth and the capacity for industry stakeholders to work together to get things done," said Robert K. Coughlin, President & CEO of MassBio. "We’re thrilled to have such a well-respected, growing, global company join the Massachusetts supercluster."

"I join the Governor in welcoming Mediso USA to Massachusetts," said Tom Gradel, Acting Director of the Massachusetts Office of International Trade & Investment. "Mediso USA will join a broad and deep ecosystem in the global hub of life sciences."

Mediso USA’s new office is based at:

Mediso USA, LLC
2 Oliver Street
Suite 613
Boston, MA 02109
USA

Media Contacts:

Illes Muller
Managing Partner, Mediso USA & Director of NA operations, Mediso
This email address is being protected from spambots. You need JavaScript enabled to view it.
+1 617 933 8771

Angus G. McQuilken
Vice President for Communications & Marketing
Massachusetts Life Sciences Center
This email address is being protected from spambots. You need JavaScript enabled to view it.
+1 617 921 7749

About Mediso USA and Mediso Medical Imaging Systems

Mediso USA is the affiliate company of Mediso Medical Imaging Systems and is based in Boston, Massachusetts. Mediso (founded in 1990) is one of the world's largest suppliers of various medical diagnostic and research purpose, single and multimodality imaging devices. The company offers complete solutions from hardware design to evaluation and quantification software both for clinical patient care and high-level life science research, including 4 imaging modalities - SPECT, PET, CT, MRI - for professionals working in laboratories and nuclear medicine departments. Mediso products are sold worldwide directly and through a network of distributors.

The company also offers nanoScan in vivo preclinical small-animal imagers for the molecular imaging field, including PET, SPECT, X-ray CT and MRI scanning, and MultiCell small-animal environment systems to provide support and monitoring functions to lab animals during the preparation stage and the imaging process enabling 4D-, 5D imaging applications. Fulfilling all the demands of growing research requirements, nanoScan products are versatile in their in-line combinations of the systems based on common software, common animal handling platforms, and easy, on-site upgrade possibility. The products and support services are offered to universities, research hospitals, government laboratories, pharmaceutical companies and contract research organizations in the North America region.

There are more than 100 preclinical systems and 900 clinical imaging systems operating in more than 86 countries around the world. Mediso also successfully runs two complex clinical diagnostic, research and teaching centers and offers clinical and evaluation software trainings for the international medical community. For more information, visit www.medisousa.com.

About the Massachusetts Life Sciences Center

The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a 10-year, $1-billion  initiative that was signed into law in June of 2008. The MLSC’s mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties among sectors of the Massachusetts life sciences community. For more information, visit www.masslifesciences.com.

This announcement is not intended to be a commercial endorsement by the MLSC of any products or services provided or developed by the entities referenced in this release.